echinocystic acid has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, J; Ma, H; Wang, Y; Wang, Z; Yao, Z; Yu, J; Zhang, L; Zhang, W; Zhuang, C | 1 |
| Cao, X; Chen, B; Chen, J; Li, W; Song, L; Wang, S; Wang, X; Xu, Y; Yu, H; Zhao, Y | 1 |
2 other study(ies) available for echinocystic acid and Cerebral Infarction, Middle Cerebral Artery
| Article | Year |
|---|---|
Discovery of bardoxolone derivatives as novel orally active necroptosis inhibitors.
Topics: Administration, Oral; Animals; Cell Survival; Cells, Cultured; Dose-Response Relationship, Drug; Drug Discovery; Female; Humans; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Inbred C57BL; Molecular Structure; Necroptosis; Oleanolic Acid; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Systemic Inflammatory Response Syndrome | 2021 |
Echinocystic acid, a natural plant extract, alleviates cerebral ischemia/reperfusion injury via inhibiting the JNK signaling pathway.
Topics: Animals; Apoptosis; Behavior, Animal; Dose-Response Relationship, Drug; Infarction, Middle Cerebral Artery; JNK Mitogen-Activated Protein Kinases; Male; MAP Kinase Signaling System; Mice; Mice, Inbred ICR; Oleanolic Acid; Phosphorylation; Reperfusion Injury; Transcription Factor RelA | 2019 |